Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Integrins and cancer

J A Varner1, D A Cheresh

  • 1Department of Medicine, University of California, San Diego, University Center 303, 9500 Gilman Drive, La Jolla, CA 92093-0063, USA. jvarner@ucsd.edu

Current Opinion in Cell Biology
|October 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

EGFR-dependent pancreatic carcinoma cell metastasis through Rap1 activation.

Oncogene·2011
Same author

Immunohistological markers of cerebrovascular integrity.

Methods in molecular medicine·2011
Same author

Oncogenic Ras/Src cooperativity in pancreatic neoplasia.

Oncogene·2011
Same author

Regulation of angiogenesis: apoptotic cues from the ECM.

Oncogene·2008
Same author

Intrinsic FAK activity and Y925 phosphorylation facilitate an angiogenic switch in tumors.

Oncogene·2006
Same author

Circulating endothelial progenitor cells.

British journal of cancer·2005
Same journal

Mechanosensing in immune cells: Implications for migration and beyond.

Current opinion in cell biology·2026
Same journal

Emerging role of organelles in cell migration.

Current opinion in cell biology·2026
Same journal

Nuclear adaptation in cell migration.

Current opinion in cell biology·2026
Same journal

Patterns in motion: Choreographing dynamic cell behaviours during tissue repair.

Current opinion in cell biology·2026
Same journal

Quo vadis reconstituted cell surfaces? Purpose and future perspectives for minimal systems of the cell plasma membrane.

Current opinion in cell biology·2026
Same journal

Nuclear determinants of mRNA and protein isoforms.

Current opinion in cell biology·2026
See all related articles

Integrins play key roles in cancer, particularly integrin alphavbeta3, which drives tumor neovascularization and melanoma progression. This research highlights integrin functions in cancer cell survival, proliferation, and metastasis.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • Integrins are crucial cell surface receptors involved in cell adhesion and signaling.
  • Recent advances have elucidated significant roles for integrins in various cancer processes.
  • Integrin alphavbeta3 is specifically implicated in tumor neovascularization.

Purpose of the Study:

  • To summarize the significant roles of integrins in cancer cells.
  • To highlight the specific involvement of integrin alphavbeta3 in tumor biology.
  • To discuss the contribution of integrin alphavbeta3 to melanoma progression.

Main Methods:

  • Literature review of recent advances in integrin research in cancer.
  • Analysis of studies implicating integrin alphavbeta3 in tumor neovascularization.

Related Experiment Videos

  • Examination of data on integrin alphavbeta3's role in melanoma survival and metastasis.

    • Main Results:

    • Integrins regulate critical cancer cell functions including signal transduction, gene expression, proliferation, apoptosis, invasion, metastasis, and angiogenesis.
    • Integrin alphavbeta3 is a key mediator of tumor neovascularization.
    • Integrin alphavbeta3 significantly contributes to the survival, proliferation, and metastatic phenotype of human melanoma.

    Conclusions:

    • Integrins are vital players in cancer development and progression.
    • Integrin alphavbeta3 represents a promising therapeutic target for inhibiting tumor growth and metastasis.
    • Targeting integrin alphavbeta3 may offer new strategies for melanoma treatment.